Tiziana Life Sciences Ltd logo

Tiziana Life Sciences Ltd

NAS:TLSA (Bermuda)   Ordinary Shares
$ 0.78 +0.0214 (+2.84%) 04:00 PM EST
At Loss
P/B:
5.96
Market Cap:
$ 77.74M
Enterprise V:
$ 69.35M
Volume:
2.50M
Avg Vol (2M):
149.26K
Also Trade In:
Volume:
2.50M
At Loss
Avg Vol (2M):
149.26K

Business Description

Tiziana Life Sciences Ltd logo
Tiziana Life Sciences Ltd

ISIN : BMG889121031

Share Class Description:

TLSA: Ordinary Shares
Description
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of highly qualified executives with extensive drug development and commercialization experience.
Name Current Vs Industry Vs History
Cash-To-Debt 18.69
Equity-to-Asset 0.76
Debt-to-Equity 0.03
Debt-to-EBITDA -0.02
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -15.1
3-Year EPS without NRI Growth Rate -14.2
3-Year FCF Growth Rate -40.2
Name Current Vs Industry Vs History
5-Day RSI 88.79
9-Day RSI 82.8
14-Day RSI 77.37
6-1 Month Momentum % -27.46
12-1 Month Momentum % -55.29

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.85
Quick Ratio 3.85
Cash Ratio 1.67

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -13.8
Name Current Vs Industry Vs History
ROE % -93.29
ROA % -74.04
ROIC % -443.41
ROC (Joel Greenblatt) % -7764.54
ROCE % -92.6